Skip to main content

Table 2 Comparison of ocular clinical features of patients with CMV-positive and CMV-negative Posner-Schlossman syndrome

From: Clinical characteristics of virus-related uveitic secondary glaucoma: focus on cytomegalovirus and varicella zoster virus

Characteristics

CMV-Negative

Patients (N = 22)

CMV-Positive

Patients (N = 25)

P Valuea

IOP at the clinic visit (mm Hg)

29.6 (24.5–34.8)

29.0 (25.0–33.0)

.839

Peak IOP (mm Hg)

48.5 (44.4–52.6)

49.2 (41.3–57.1)

.235

Cup-to-disc ratio

0.5 (0.4–0.5)

0.6 (0.5–0.6)

.043*

Corrected visual acuity

 logMAR

0.1 (0.02–0.2)

0.3 (0.01–0.6)

.554

 Decimal (minutes)

0.8 (0.7–0.9)

0.8 (0.6–0.9)

.554

CEC density of the diseased eye (cell/mm2)

2490.6 (2320.8–2660.5)

2196.3 (2020.9–2371.8)

.017*

CEC destiny of the healthy eye (cell/mm2)

2756.6 (2596.3–2916.9)

2828.5 (2702.2–2954.8)

.448

Relative CEC loss (%)

9.6 (5.9–13.3)

22.1 (16.3–27.9)

.001*

KPs

 -Mutton-fat

19 (86.36)

25 (100)

.095

 -Coin-shaped

5 (22.7)

6 (24.0)

.894

Tyndall effect

3 (13.6)

3 (12.0)

1.000

Iris depigmentation

9 (40.9)

20 (80.0)

.006*

Cataract

6 (27.3)

13 (52.0)

.085

  1. Data are expressed as mean (95% C.I) or number of patients (%)
  2. IOP Intraocular pressure, CEC Corneal endothelial cell, KPs Keratic precipitates
  3. aχ2 test or Fisher’s exact test was used to compare proportions between CMV-negative and CMV-positive PSS; Mann-Whitney U test was used to compare continuous variables between CMV-negative and CMV-positive PSS
  4. *p < .05